' significant resolutions as follows: 1. Approved to propose to the Extraordinary General Meeting of the Shareholders No. 1/2018 (the “EGM”) for consideration and approval of the reduction of the Company’s
comply with Clause 8 to Clause 12. In the case where management company shall provide an operating system under paragraph one, such operating system shall have an approval from the Office before investing
performance shall comply with Clause 8 to Clause 12. In the case where management company shall provide an operating system under paragraph one, such operating system shall have an approval from the Office
, Soi Surawong, Si Phraya, Bang Rak, Bangkok 10500, with the agenda as per Attachment 1. 2. Approval that the date of 25th June, 2020 is the date to determine the rights of shareholders for their
shall provide an operating system under paragraph one, such operating system shall have an approval from the Office before investing or additional investing in proprietary trading Clause 8. Management
share, and the proposal of this matter to the shareholders’ meeting for further consideration and approval; 2. Approved the amendment of Clause 4 of the Memorandum of Association of the Company to be in
manufacturing cosmeceuticals and modern medicine from FDA and controlled quality and operational efficiency which certified by international standards ISO 9001:2008, GMP, PICS, HACCP และ HALAL. Presently, At-Ze
located in Muang district, Chachoengsao province and authorized manufacturing cosmeceuticals and modern medicine from FDA and controlled quality and operational efficiency which certified by international
from FDA and controlled quality and operational efficiency which certified by international standards ISO 9001:2008, GMP, PICS, HACCP และ HALAL. Registered capital THB 50 million, divided into 500,000
tracking the risk management results, to find out that they are controlled and managed in the acceptable levels. From the following reasons concluding that the operating results of the Company in the year